We have located links that may give you full text access.
Effects of pulse duration on muscle fatigue during electrical stimulation inducing moderate-level contraction.
Muscle & Nerve 2018 April
INTRODUCTION: Neuromuscular electrical stimulation (NMES) is used to prevent muscle atrophy. However, the effect of pulse duration modulation for reducing muscle fatigue and pain is unknown.
METHODS: Two 2-minute stimulation protocols were applied to the knee extensors of 10 healthy individuals. In 1 session, a long pulse duration (1,000 μs) and a low current amplitude (LL), set to evoke 25% maximal voluntary contraction at 30 Hz, were applied. The other session was identical except that a short pulse duration (200 μs) and a high current amplitude (SH) were used.
RESULTS: Muscle fatigue was lower for LL than for SH (P < 0.01). Force recovery rate was higher for LL than for SH (P < 0.05). Pain scores were also lower for LL than for SH (P < 0.05).
DISCUSSION: The use of 1-ms pulse durations reduces fatigue and pain during NMES for moderate-level contractions compared with 200-μs durations. Muscle Nerve 57: 642-649, 2018.
METHODS: Two 2-minute stimulation protocols were applied to the knee extensors of 10 healthy individuals. In 1 session, a long pulse duration (1,000 μs) and a low current amplitude (LL), set to evoke 25% maximal voluntary contraction at 30 Hz, were applied. The other session was identical except that a short pulse duration (200 μs) and a high current amplitude (SH) were used.
RESULTS: Muscle fatigue was lower for LL than for SH (P < 0.01). Force recovery rate was higher for LL than for SH (P < 0.05). Pain scores were also lower for LL than for SH (P < 0.05).
DISCUSSION: The use of 1-ms pulse durations reduces fatigue and pain during NMES for moderate-level contractions compared with 200-μs durations. Muscle Nerve 57: 642-649, 2018.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app